{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:40:41Z","timestamp":1777894841378,"version":"3.51.4"},"reference-count":15,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T00:00:00Z","timestamp":1550707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Optimal treatment for transformed follicular lymphoma (<jats:styled-content style=\"fixed-case\">tFL<\/jats:styled-content>) is not fully defined. Clinical characteristics and treatments that impact on post\u2010transformation outcome of 176 biopsy\u2010proven <jats:styled-content style=\"fixed-case\">tFL<\/jats:styled-content> were analysed. Transformation occurred at initial diagnosis in 52% (Group 1) and after a <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content> diagnosis in 48% (Group 2). Five\u2010year overall survival was 84% for Group 1 and 51% for Group 2 (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b7001). In Group 1, 5\u2010year progression\u2010free survival was superior after rituximab maintenance compared to observation only (94% vs. 53%, <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7024). In Group 2, an inverse trend was found between survival and both a higher number of pre\u2010transformation treatment lines and a short time\u2010to\u2010transformation.<\/jats:p>","DOI":"10.1111\/bjh.15816","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T03:51:12Z","timestamp":1550807472000},"page":"713-717","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (<scp>FIL<\/scp>)"],"prefix":"10.1111","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0359-767X","authenticated-orcid":false,"given":"Chiara","family":"Rusconi","sequence":"first","affiliation":[{"name":"Division of Haematology Department of Haematology and Oncology Niguarda Cancer Center ASST Grande Ospedale Metropolitano Niguarda Milan Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Anastasia","sequence":"additional","affiliation":[{"name":"Haematology ASST Spedali Civili di Brescia Brescia Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Chiarenza","sequence":"additional","affiliation":[{"name":"Division of Haematology A.U.O. Policlinico\u2010Vittorio Emanuele\u2010Ferrarotto Catania Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Marcheselli","sequence":"additional","affiliation":[{"name":"Department of Diagnostic, Clinical and Public Health Medicine University of Modena and Reggio Emilia Modena Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Cavallo","sequence":"additional","affiliation":[{"name":"Haematology, S.C.D.U. Ematologia Universitaria, Azienda Ospedaliera Citt\u00e0 della Salute e della Scienza Turin Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Rattotti","sequence":"additional","affiliation":[{"name":"Department of Haematology Oncology Fondazione IRCCS Policlinico San Matteo and Department of Molecular Medicine University of Pavia Pavia Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Botto","sequence":"additional","affiliation":[{"name":"SC Ematologia Azienda Ospedaliera Citt\u00e0 della Salute e della Scienza Torino Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9984-1146","authenticated-orcid":false,"given":"Angela","family":"Ferrari","sequence":"additional","affiliation":[{"name":"AUSL\u2010IRCCS Reggio Emilia Hematology Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Nassi","sequence":"additional","affiliation":[{"name":"Ematologia Azienda Ospedaliero Universitaria Maggiore della Carit\u00e0 Novara Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Pagani","sequence":"additional","affiliation":[{"name":"Haematology ASST Spedali Civili di Brescia Brescia Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Meli","sequence":"additional","affiliation":[{"name":"Division of Haematology Department of Haematology and Oncology Niguarda Cancer Center ASST Grande Ospedale Metropolitano Niguarda Milan Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9504-991X","authenticated-orcid":false,"given":"Luca","family":"Arcaini","sequence":"additional","affiliation":[{"name":"Department of Haematology Oncology Fondazione IRCCS Policlinico San Matteo and Department of Molecular Medicine University of Pavia Pavia Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Federico","sequence":"additional","affiliation":[{"name":"Department of Diagnostic, Clinical and Public Health Medicine University of Modena and Reggio Emilia Modena Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Rossi","sequence":"additional","affiliation":[{"name":"Haematology ASST Spedali Civili di Brescia Brescia Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of Fondazione Italiana Linfomi (FIL)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,2,21]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12570"},{"key":"e_1_2_8_3_1","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1182\/blood.V130.Suppl_1.828.828","article-title":"Diffuse large B\u2010cell lymphomas transformed from or with concurrent follicular lymphoma demonstrate similar clinical outcomes as de\u2010novo diffuse large B\u2010cell lymphomas, except for cases harboring double hit rearrangements","volume":"130","author":"Behad A.","year":"2017","journal-title":"Blood"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.2403"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30090-5"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.5671"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-013-1991-y"},{"key":"e_1_2_8_8_1","first-page":"411","article-title":"Maintenance rituximab following induction R\u2010CHOP chemotherapy in patients with composite or discordant, indolent and aggressive","volume":"101","author":"Kansara R.","year":"2016","journal-title":"B\u2010Cell non\u2010Hodgkin Lymphomas. Haematologica"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2303-5"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.48.3990"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu537"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx407"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2015.1.625"},{"key":"e_1_2_8_14_1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow S.H.","year":"2008"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.73.3402"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-621375"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjh.15816","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.15816","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjh.15816","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.15816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T12:40:04Z","timestamp":1694349604000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.15816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,21]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1111\/bjh.15816"],"URL":"https:\/\/doi.org\/10.1111\/bjh.15816","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,21]]},"assertion":[{"value":"2018-09-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}